tiprankstipranks
Advertisement
Advertisement

SMMT Stock Latest News

Summit Therapeutics management to meet with Cantor
The FlySummit Therapeutics management to meet with Cantor
11h ago
SMMT
Summit Therapeutics Joins Elite List of Trending Analyst Calls
PremiumWeekend Updates
Summit Therapeutics Joins Elite List of Trending Analyst Calls
4d ago
SMMT
Midday Fly By: Estee Lauder walks from Puig, Imax reportedly explores sale
PremiumThe Fly
Midday Fly By: Estee Lauder walks from Puig, Imax reportedly explores sale
5d ago
BJ
EL
Texas Instruments, Generac upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Texas Instruments, Generac upgraded: Wall Street’s top analyst calls
5d ago
MP
ZM
Summit Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Summit Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
5d ago
SMMT
Closing Bell Movers: Workday jumps 11%, Zoom up 6% after earnings
PremiumThe FlyClosing Bell Movers: Workday jumps 11%, Zoom up 6% after earnings
5d ago
MU
ZM
Bernstein starts Summit with an Underperform, says ‘not on solid footing’
Premium
The Fly
Bernstein starts Summit with an Underperform, says ‘not on solid footing’
5d ago
SMMT
Summit Therapeutics initiated with an Underperform at Bernstein
Premium
The Fly
Summit Therapeutics initiated with an Underperform at Bernstein
5d ago
SMMT
3 Best Stocks to Buy This Week, According to Analysts – May 18-May 22
PremiumMarket News
3 Best Stocks to Buy This Week, According to Analysts – May 18-May 22
8d ago
BSX
SMMT
Unusually active option classes on open May 6th
PremiumThe Fly
Unusually active option classes on open May 6th
20d ago
AG
DIS
Tyler Van Buren Reiterates Buy on Summit Therapeutics, Citing Stable Long-Term Sales Outlook and Attractive Risk/Reward Despite Higher Future OpEx
PremiumRatings
Tyler Van Buren Reiterates Buy on Summit Therapeutics, Citing Stable Long-Term Sales Outlook and Attractive Risk/Reward Despite Higher Future OpEx
21d ago
SMMT
Summit Therapeutics price target lowered to $23 from $30 at H.C. Wainwright
PremiumThe Fly
Summit Therapeutics price target lowered to $23 from $30 at H.C. Wainwright
23d ago
SMMT
Summit Therapeutics Flags Significant Going-Concern Risk Amid Cash Shortfall and Uncertain Financing
PremiumCompany AnnouncementsSummit Therapeutics Flags Significant Going-Concern Risk Amid Cash Shortfall and Uncertain Financing
25d ago
SMMT
Midday Fly By: Apple reports Q2 beat, oil majors post mixed results
Premium
The Fly
Midday Fly By: Apple reports Q2 beat, oil majors post mixed results
26d ago
AN
BP
Summit Therapeutics falls -23.7%
Premium
The Fly
Summit Therapeutics falls -23.7%
26d ago
SMMT
Summit Therapeutics falls -27.4%
PremiumThe Fly
Summit Therapeutics falls -27.4%
26d ago
SMMT
Summit Therapeutics price target lowered to $16 from $17 at Piper Sandler
PremiumThe Fly
Summit Therapeutics price target lowered to $16 from $17 at Piper Sandler
26d ago
SMMT
Summit Therapeutics: Buy/High Risk Rating Reiterated as Analyst Sees Attractive Upside to Unchanged $40 Target Despite HARMONi-3 Interim Miss
PremiumRatings
Summit Therapeutics: Buy/High Risk Rating Reiterated as Analyst Sees Attractive Upside to Unchanged $40 Target Despite HARMONi-3 Interim Miss
26d ago
SMMT
Summit Therapeutics price target lowered to $31 from $32 at Clear Street
PremiumThe Fly
Summit Therapeutics price target lowered to $31 from $32 at Clear Street
26d ago
SMMT
Summit Therapeutics reports Q1 adjusted EPS (15c), consensus (21c)
PremiumThe FlySummit Therapeutics reports Q1 adjusted EPS (15c), consensus (21c)
26d ago
SMMT
Summit Therapeutics options imply 7.3% move in share price post-earnings
Premium
The Fly
Summit Therapeutics options imply 7.3% move in share price post-earnings
27d ago
SMMT
Summit Therapeutics put volume heavy and directionally bearish
Premium
The Fly
Summit Therapeutics put volume heavy and directionally bearish
1M ago
SMMT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >